Indivior Pharmaceuticals, Inc.
INDV
$33.34
$0.742.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 195.00M | 445.00M | 510.00M | 373.00M | 320.00M |
| Total Receivables | 255.00M | 272.00M | 243.00M | 272.00M | 287.00M |
| Inventory | 153.00M | 155.00M | 149.00M | 163.00M | 167.00M |
| Prepaid Expenses | 34.00M | 30.00M | 28.00M | 56.00M | 31.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.00M | 20.00M | 21.00M | 19.00M | 22.00M |
| Total Current Assets | 652.00M | 922.00M | 951.00M | 883.00M | 827.00M |
|
|
|||||
| Total Current Assets | 652.00M | 922.00M | 951.00M | 883.00M | 827.00M |
| Net Property, Plant & Equipment | 170.00M | 154.00M | 152.00M | 141.00M | 139.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.00M | 2.00M | 7.00M | 7.00M | 6.00M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 349.00M | 310.00M | 315.00M | 317.00M | 317.00M |
| Total Assets | 1.20B | 1.42B | 1.45B | 1.38B | 1.32B |
|
|
|||||
| Total Accounts Payable | 48.00M | 41.00M | 50.00M | 46.00M | 63.00M |
| Total Accrued Expenses | 784.00M | 787.00M | 855.00M | 812.00M | 715.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 39.00M | 28.00M | 29.00M | 29.00M | 28.00M |
| Total Finance Division Other Current Liabilities | 43.00M | 109.00M | 122.00M | 118.00M | 118.00M |
| Total Other Current Liabilities | 43.00M | 109.00M | 122.00M | 118.00M | 118.00M |
| Total Current Liabilities | 914.00M | 965.00M | 1.06B | 1.01B | 924.00M |
|
|
|||||
| Total Current Liabilities | 914.00M | 965.00M | 1.06B | 1.01B | 924.00M |
| Long-Term Debt | 290.00M | 304.00M | 308.00M | 311.00M | 315.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.00M | 24.00M | 29.00M | 30.00M | 32.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 73.00M | 330.00M | 316.00M | 314.00M | 382.00M |
| Total Liabilities | 1.30B | 1.62B | 1.71B | 1.66B | 1.65B |
|
|
|||||
| Common Stock & APIC | 174.00M | 171.00M | 163.00M | 155.00M | 152.00M |
| Retained Earnings | -243.00M | -346.00M | -388.00M | -406.00M | -443.00M |
| Treasury Stock & Other | -29.00M | -32.00M | -32.00M | -34.00M | -46.00M |
| Total Common Equity | -98.00M | -207.00M | -257.00M | -285.00M | -337.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -98.00M | -207.00M | -257.00M | -285.00M | -337.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -98.00M | -207.00M | -257.00M | -285.00M | -337.00M |
|
|
|||||